Lantern Pharma Advances Development of Molecular Diagnostic for Oncology Clinical Trials
Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company, has reached a milestone in the development of a diagnostic tool for …
#Biomarkers Development
![[Interview] Hacking Metabolomics With AI To …](/files/blog/20200513_170730.1003_Olaris_teampic_waterfront.jpg)
[Interview] Hacking Metabolomics With AI To Improve Clinical Research
Personalized medicine has become a paradigm-shifting trend in healthcare - the hegemony of “one-size-fits-all” drugs is increasingly challenged by novel innovative …